透析設備市場商機、成長要素、產業趨勢分析及2026-2035年預測。

全球透析設備市場預計到 2025 年將價值 48 億美元，預計到 2035 年將以 5.1% 的複合年成長率成長至 77 億美元。

透析需求的成長是由多種因素共同推動的，包括器官捐贈供不應求、末期腎病病例增加以及代謝性疾病盛行率上升。技術進步也發揮著至關重要的作用，人工智慧和物聯網整合的透析系統提高了監測精度、治療個人化和營運效率。居家透析解決方案的日益普及，以及需要長期照護的老年人口不斷成長，進一步推動了透析需求。此外，人們對早期診斷和治療腎臟疾病重要性的認知不斷提高，也促進了及時醫療介入。隨著醫療保健系統的不斷發展，透析設備製造商正致力於創新、便攜性和以患者為中心的功能，以改善不同醫療環境下的治療效果和可近性。

預計到2025年，血液透析市佔率將達到87.9%，繼續維持其作為進行性腎臟病主要治療方法的主導地位。設備性能、使用者介面和治療效率的持續改進正在推動該領域的成長。安全性的提升、治療時間的縮短以及患者舒適度的提高正在促進血液透析的普及。由於慢性腎臟病在全球範圍內的盛行率仍然居高不下，醫療機構仍然高度依賴血液透析系統來提供持續有效的患者照護，這進一步推動了該領域的擴張。

預計到2025年，院內透析市場規模將達到38億美元，反映了其在市場上的主導地位。系統化的治療環境、專業的醫護人員以及先進的設備仍然深受患者青睞。這些機構提供持續的監測和可控的治療環境，有助於改善患者的治療效果和信心。此外，有利的報銷機制和保險覆蓋範圍也使院內透析成為一種廣泛可及的選擇，從而支撐了該領域的持續需求。

預計到2025年，美國透析設備市場規模將達到20億美元，主要得益於透析療法的日益普及、醫療技術的進步以及有利的醫保報銷政策。成熟的產業參與企業和持續的創新投入進一步鞏固了區域市場格局。此外，隨著人們對透析的認知不斷提高、教育力度加大以及小型化、易用型設備的進步，居家透析解決方案的興起提高了患者的柔軟性和便利性。

目錄

第1章：調查方法

• 研究途徑
• 品質改進計劃
  • GMI人工智慧政策及對資料完整性的承諾
    • 資訊來源一致性協議
• 調查過程和可靠性評分
  • 研究路徑的組成部分
  • 評分組成部分
• 數據收集
  • 主要來源部分列表
• 資料探勘資訊來源
  • 付費資訊來源
    • 區域資訊來源
• 基本估算和計算方法
  • 基準年的計算
• 預測模型
  • 量化市場影響分析
    • 生長參數對預測的數學影響
• 關於調查透明度的補充信息
  • 資訊來源歸屬框架
  • 品質保證指標
  • 對信任的承諾

第2章執行摘要

第3章業界考察

• 生態系分析
• 影響產業的因素
  • 促進因素
    • 末期腎功能衰竭（ESRD）患者數量增加
    • 糖尿病發生率增加
    • 捐贈腎臟短缺
    • 透析治療可享有優惠的報銷方案。
  • 產業潛在風險與挑戰
    • 產品召回
    • 治療併發症
  • 機會
    • 居家血液透析及腹膜透析的發展
    • 攜帶式和穿戴式式透析系統的開發
• 成長潛力分析
• 監理情勢（基於初步調查）
  • 北美洲
  • 歐洲
  • 亞太地區
• 科技與創新趨勢
  • 當前技術趨勢
  • 新興技術
• 未來市場趨勢（基於初步研究）
• 目前居家透析狀況
• 救贖方案
• 人工智慧和生成式人工智慧對市場的影響（基於初步研究）
  • 利用人工智慧改造現有經營模式
  • 針對特定領域的生成式人工智慧應用案例和實施藍圖
• 差距分析
• 波特五力分析
• PESTEL 分析

第4章 競爭情勢

• 介紹
• 企業矩陣分析
• 企業市佔率分析（基於初步研究）
  • 世界
  • 北美洲
  • 歐洲
  • 亞太地區
• 主要市場公司的競爭分析
• 競爭定位矩陣
• 主要進展
  • 併購
  • 夥伴關係與合作
  • 新產品發布
  • 業務拓展計劃

第5章 市場估算與預測：依產品類型分類，2022-2035年

• 血液透析機
• 腹膜透析機

第6章 市場估算與預測：依最終用途分類，2022-2035年

• 院內透析
• 居家透析

第7章 市場估計與預測：依地區分類，2022-2035年

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第8章：公司簡介

• B. Braun
• Baxter International
• Dialife SA
• Fresenius Medical Care
• JMS Co., Ltd.
• Medtronic
• Nikkiso
• Nipro
• Outset Medical
• Quanta Dialysis Technologies
• Toray Medical

The Global Dialysis Machines Market was valued at USD 4.8 billion in 2025 and is estimated to grow at a CAGR of 5.1% to reach USD 7.7 billion by 2035.

Growth is supported by a combination of factors, including the limited availability of donor organs, increasing cases of end-stage renal disease, and the expanding prevalence of metabolic disorders. Technological progress is also playing a central role, as AI-enabled and IoT-integrated dialysis systems improve monitoring accuracy, treatment personalization, and operational efficiency. The rising adoption of home-based dialysis solutions, along with a growing elderly population requiring long-term care, is further strengthening demand. Additionally, increasing awareness around early diagnosis and treatment of kidney disorders is encouraging timely medical intervention. As healthcare systems continue to evolve, dialysis equipment manufacturers are focusing on innovation, portability, and patient-centric features to enhance treatment outcomes and accessibility across diverse care settings.

The hemodialysis machines segment accounted for a share of 87.9% in 2025, maintaining its leadership due to its widespread adoption as a primary treatment method for advanced kidney conditions. Continuous improvements in device performance, user interface, and treatment efficiency are supporting segment growth. Enhanced safety features, reduced treatment time, and improved patient comfort are encouraging higher acceptance rates. As the incidence of chronic kidney disorders persists globally, healthcare providers continue to rely heavily on hemodialysis systems for consistent and effective patient care, further reinforcing segment expansion.

The in-center dialysis segment generated USD 3.8 billion in 2025, reflecting its dominant position in the market. Structured treatment environments, access to specialized medical staff, and the availability of advanced equipment contribute to its continued preference among patients. These facilities offer consistent monitoring and controlled treatment conditions, which help improve patient outcomes and confidence. Favorable reimbursement frameworks and insurance coverage also make in-center dialysis a widely accessible option, supporting sustained demand within this segment.

United States Dialysis Machines Market reached USD 2 billion in 2025, driven by strong adoption of dialysis therapies, advancements in medical technologies, and supportive reimbursement policies. The presence of established industry participants and ongoing investments in innovation further strengthen the regional landscape. Additionally, the growing shift toward home-based dialysis solutions is improving patient flexibility and convenience, supported by increased awareness, education initiatives, and advancements in compact and user-friendly devices.

Key companies operating in the Global Dialysis Machines Market include B. Braun, Baxter International, Dialife SA, Fresenius Medical Care, JMS Co., Ltd., Medtronic, Nikkiso, Nipro, Outset Medical, Quanta Dialysis Technologies, and Toray Medical. Companies in the Global Dialysis Machines Market are strengthening their competitive position through continuous innovation, strategic partnerships, and expansion of product portfolios. They are investing in advanced technologies such as AI-enabled monitoring systems, portable dialysis devices, and IoT-integrated solutions to enhance treatment efficiency and patient experience. Many players are focusing on expanding home dialysis offerings to tap into the growing demand for convenient care solutions. Collaborations with healthcare providers and research institutions help accelerate product development and clinical validation. Additionally, companies are increasing their global footprint through mergers, acquisitions, and distribution network expansion. Emphasis on cost optimization, regulatory compliance, and improved after-sales services further supports long-term market growth and brand positioning.

Table of Contents

Chapter 1 Research Methodology

• 1.1 Research approach
• 1.2 Quality commitments
  • 1.2.1 GMI AI policy & data integrity commitment
    • 1.2.1.1 Source consistency protocol
• 1.3 Research trail & confidence scoring
  • 1.3.1 Research trail components
  • 1.3.2 Scoring components
• 1.4 Data collection
  • 1.4.1 Partial list of primary sources
• 1.5 Data mining sources
  • 1.5.1 Paid sources
    • 1.5.1.1 Sources, by region
• 1.6 Base estimates and calculations
  • 1.6.1 Base year calculation
• 1.7 Forecast model
  • 1.7.1 Quantified market impact analysis
    • 1.7.1.1 Mathematical impact of growth parameters on forecast
• 1.8 Research transparency addendum
  • 1.8.1 Source attribution framework
  • 1.8.2 Quality assurance metrics
  • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Product type trends
  • 2.2.3 End use trends
• 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising number of end stage renal diseases (ESRD) patients
    • 3.2.1.2 Increasing incidence of diabetes
    • 3.2.1.3 Shortage of donor kidneys
    • 3.2.1.4 Favorable reimbursement scenario available for dialysis treatment
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Product recalls
    • 3.2.2.2 Complication in the treatment
  • 3.2.3 Opportunities
    • 3.2.3.1 Growth of home hemodialysis and peritoneal dialysis
    • 3.2.3.2 Development of portable and wearable dialysis systems
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape (Driven by Primary Research)
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
• 3.5 Technology and innovation landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Future market trends (Driven by Primary Research)
• 3.7 Home dialysis landscape
• 3.8 Reimbursement scenario
• 3.9 Impact of AI & generative AI on the market (Driven by Primary Research)
  • 3.9.1 AI-Driven disruption of existing business models
  • 3.9.2 GenAI use cases & adoption roadmap by segment
• 3.10 Gap analysis
• 3.11 Porter's analysis
• 3.12 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis (Driven by Primary Research)
  • 4.3.1 Global
  • 4.3.2 North America
  • 4.3.3 Europe
  • 4.3.4 Asia Pacific
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Hemodialysis machines
• 5.3 Peritoneal dialysis machines

Chapter 6 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 In-center dialysis
• 6.3 Home center dialysis

Chapter 7 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Netherlands
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 South Korea
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
• 7.6 MEA
  • 7.6.1 South Africa
  • 7.6.2 Saudi Arabia
  • 7.6.3 UAE

Chapter 8 Company Profiles

• 8.1 B. Braun
• 8.2 Baxter International
• 8.3 Dialife SA
• 8.4 Fresenius Medical Care
• 8.5 JMS Co., Ltd.
• 8.6 Medtronic
• 8.7 Nikkiso
• 8.8 Nipro
• 8.9 Outset Medical
• 8.10 Quanta Dialysis Technologies
• 8.11 Toray Medical